Sara Buonomo: Predicting Relapse in Immune-Mediated TTP at ISTH 2026
Sara Buonomo, PhD Student in Haematology and Doctoral Candidate at University of Bern, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“I am delighted to share that I will present a poster (PB1097) at the 34th Annual Congress of the International Society on Thrombosis and Haemostasis ISTH 2026 in Paris this Sunday 12th July at 13:45 – 14:45 CEST.
Title: Longitudinal profiling of platelet factor 4 suggests platelet activation precedes clinical relapse in immune-mediated thrombotic thrombocytopenic purpura.
In this poster we are reporting the results from our newest publication on the role of NETs in iTTP, as well as new results from a longitudinal analysis of PF4 plasma levels in iTTP patients.”
Title: NETs contribute to acute episodes but not ADAMTS13 relapses in immune-mediated thrombotic thrombocytopenic purpura
Authors: Sara M. Buonomo, Marissa Schraner, Tanja Muralt, Monica Schaller, Johanna A. Kremer Hovinga
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight